Education
About Us
Working with TipRanks
Follow Us
Coeptis Therapeutics Holdings (COEP)
NASDAQ:COEP
RESEARCH TOOLSreports
Total Valuation
Coeptis Therapeutics Holdings has a market cap or net worth of $34.15M. The enterprise value is ―.
Market Cap$34.15M
Enterprise Value―
Share Statistics
Coeptis Therapeutics Holdings has 3,513,838 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,513,838
Owned by Insiders3.03%
Owned by Institutions―
Financial Efficiency
Coeptis Therapeutics Holdings’s return on equity (ROE) is -3.08 and return on invested capital (ROIC) is -162.47%.
Return on Equity (ROE)-3.08
Return on Assets (ROA)-1.10
Return on Invested Capital (ROIC)-162.47%
Return on Capital Employed (ROCE)-2.29
Revenue Per Employee0.00
Profits Per Employee-2.18M
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Coeptis Therapeutics Holdings is -1.08. Coeptis Therapeutics Holdings’s PEG ratio is >-0.01.
PE Ratio-1.08
PS Ratio0.00
PB Ratio5.67
Price to Fair Value3.32
Price to FCF-4.57
Price to Operating Cash Flow-2.72
PEG Ratio>-0.01
Income Statement
In the last 12 months, Coeptis Therapeutics Holdings had revenue of 0.00 and earned -9.81M in profits. Earnings per share was -5.10.
Revenue0.00
Gross Profit0.00
Operating Income-10.05M
Pretax Income-10.88M
Net Income-9.81M
EBITDA-10.05M
Earnings Per Share (EPS)-5.10
Cash Flow
In the last 12 months, operating cash flow was -6.65M and capital expenditures 0.00, giving a free cash flow of -6.65M billion.
Operating Cash Flow-6.65M
Free Cash Flow-6.65M
Free Cash Flow per Share-1.89
Dividends & Yields
Coeptis Therapeutics Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.06
52-Week Price Change62.69%
50-Day Moving Average9.55
200-Day Moving Average6.79
Relative Strength Index (RSI)52.99
Average Volume (3m)78.66K
Important Dates
Coeptis Therapeutics Holdings upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Coeptis Therapeutics Holdings as a current ratio of 0.23, with Debt / Equity ratio of 37.29%
Current Ratio0.23
Quick Ratio0.23
Debt to Market Cap0.11
Net Debt to EBITDA-0.07
Interest Coverage Ratio25.38
Taxes
In the past 12 months, Coeptis Therapeutics Holdings has paid -1.06M in taxes.
Income Tax-1.06M
Effective Tax Rate0.10
Enterprise Valuation
Coeptis Therapeutics Holdings EV to EBITDA ratio is -1.12, with an EV/FCF ratio of -1.69.
EV to Sales0.00
EV to EBITDA-1.12
EV to Free Cash Flow-1.69
EV to Operating Cash Flow-1.69
Balance Sheet
Coeptis Therapeutics Holdings has $532.88K in cash and marketable securities with $1.19M in debt, giving a net cash position of $654.99K billion.
Cash & Marketable Securities$532.88K
Total Debt$1.19M
Net Cash$654.99K
Net Cash Per Share$0.19
Tangible Book Value Per Share$4.07
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Coeptis Therapeutics Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―